The Food and Drug Administration is considering whether and how to regulate therapy chatbots that are based on large language models. Today, the agency’s Digital Health Advisory Committee is meeting ...
As scrutiny over AI therapy grows, licensed therapists are split on whether it’s okay to talk to chatbots about mental health.
A vitiligo research group has "hit pause" on its forthcoming AI therapy bot after learning about negative mental health effects that other chatbots have been having on users. The Vitiligo Research ...
Shares of Agenus (NASDAQ:AGEN) plunged 60% Thursday morning on news that the FDA has discouraged the company from pursuing accelerated approval for its colorectal cancer combination therapy BOT/BAL.
When your therapist is a bot, you can reach it at 2 a.m. But will it really understand your problems? Credit...Simone Noronha Supported by By Karen Brown “I understand that you’re experiencing a ...